Veterinary Medicine Information website

Lignocaine & Adrenaline Solution for Injection

Not authorised
  • EPINEPHRINE BITARTRATE
  • Lidocaine hydrochloride
Download as PDF

Product identification

Medicine name:
Lignocaine & Adrenaline Solution for Injection
Active substance:
  • EPINEPHRINE BITARTRATE
  • Lidocaine hydrochloride
Target species:
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • EPINEPHRINE BITARTRATE
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lidocaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        28
        day
  • Subcutaneous use
    • Horse
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • Lignocaine and Adrenaline Injection is marketed in 500 ml amber Type II glass vial, closed with bromobutyl rubber bung, and aluminium overseal.
  • Lignocaine and Adrenaline Injection is marketed in 100 ml amber Type II glass vial, closed with bromobutyl rubber bung, and aluminium overseal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chem-Pharm
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10823/019/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download